Greg Petersen

Director, PROS.

Companies

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

As of each latest filing. The line shows shares held over time.

Recent filings

  • Dec 9, 2025Returned to company 125,170 shares at $23.25 of PROS7
  • May 8, 2025Exercised options 6,125 shares at $16.87 of PROS8
  • Sep 11, 2024Bought 12,500 shares at $1.35 of Plus Therapeutics5
  • May 11, 2024Exercised options 7,205 shares at $30.63 of PROS9
  • May 8, 2024Bought 12,255 shares at $2.04 of Plus Therapeutics10
  • Sep 11, 2023Bought 20,000 shares at $1.70 of Plus Therapeutics11
  • May 12, 2023Sold 2,383 shares at $24.61 of PROS12
  • May 11, 2023Exercised options 6,809 shares at $24.98 of PROS12
  • Nov 4, 2022Sold 6,000 shares at $25.76 of PROS13
  • May 17, 2022Bought 30,000 shares at $0.55 of Plus Therapeutics14
  • May 13, 2022Sold 1,536 shares at $24.91 of PROS15
  • May 12, 2022Exercised options 4,388 shares at $24.23 of PROS15
  • Oct 27, 2021Bought 12,500 shares at $1.72 of Plus Therapeutics16
  • Sep 30, 2021Granted 8,449 shares of Aterian, Inc.6
  • Sep 30, 2021Granted 1,281 shares of Aterian, Inc.6